Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Share-based Compensation (2016 - 2025)

Macrogenics (MGNX) has disclosed Share-based Compensation for 13 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 76.38% to $2.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.3 million, a 51.47% decrease, with the full-year FY2025 number at $14.3 million, down 51.47% from a year prior.
  • Share-based Compensation was $2.7 million for Q4 2025 at Macrogenics, down from $3.5 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $11.3 million in Q4 2024 to a low of $2.7 million in Q4 2025.
  • A 5-year average of $5.3 million and a median of $5.2 million in 2022 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: skyrocketed 158.43% in 2024, then plummeted 76.38% in 2025.
  • Macrogenics' Share-based Compensation stood at $5.4 million in 2021, then dropped by 12.4% to $4.7 million in 2022, then fell by 8.06% to $4.4 million in 2023, then skyrocketed by 158.43% to $11.3 million in 2024, then tumbled by 76.38% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Share-based Compensation are $2.7 million (Q4 2025), $3.5 million (Q3 2025), and $3.7 million (Q2 2025).